Immuron posts record A$1.18 million monthly sales for Travelan; shares jump
Melbourne-based biopharmaceutical firm Immuron Ltd (NASDAQ:IMRN, ASX:IMC) is trading higher on revealing record monthly sales of its over-the-counter...
Stay updated with breaking news from Immuron Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Melbourne-based biopharmaceutical firm Immuron Ltd (NASDAQ:IMRN, ASX:IMC) is trading higher on revealing record monthly sales of its over-the-counter...
Australian-based and globally integrated biopharmaceutical company, Immuron Ltd (NASDAQ:IMRN, ASX:IMC), will present at The Military Health System Research...
The ASX was higher today. The S&P/ASX200 gained 25.40 points or 0.35% to 7,336.50. Over the last five days, the index is virtually unchanged but is...
Immuron Ltd (NASDAQ:IMRN, ASX:IMC) has received Therapeutic Goods Administration (TGA) GMP Clearance for its packaging supplier allowing Travelan® to be...
Over the past few years – during which a once-in-a-century pandemic made a clutch of megacap biotech companies a lot of money – the health care industry has...